OrganOx Secures $142M in Equity Financing to Drive Growth in Organ Technology

Oxford, UK and Madison, NJ, February 24, 2025 (Globe Newswire) -- OrganOx Ltd., a leading organ medical technology company, has successfully closed a $142 million equity financing round to accelerate the growth of its metra® platform in the expanding global organ technology market. The oversubscribed round was led by HealthQuest Capital, with participation from existing investors BGF and Lauxera Capital Partners, as well as new investors Sofina, Soleus Capital, and Avidity Partners. With support from the University of Oxford and other key stakeholders, the financing strengthens OrganOx’s leadership position in organ preservation and transplantation technology.

Read full article here.